CTV
Click for more information
0.00% 0.8¢ colortv limited

Ann: EN1 Operations Update on Ukraine Team, page-16

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Hashimoto
    2,009 Posts.
    lightbulb Created with Sketch. 450
    clock Created with Sketch.
    22/03/22
    06:37
    Post #: 60330828
    I wonder if Ted's GF Marina Mazepa is paying some of the rent on the office Engage BDR lease ?

    Or is this just one of the perks of being the girlfriend of the CEO/Chairman of EN1 sneaky.png

    https://hotcopper.com.au/data/attachments/4191/4191866-3be6db53c94b583acd7239df8ac3266f.jpg
    https://hotcopper.com.au/data/attachments/4191/4191869-e95cbf978d256a489915658cb311b506.jpg





    https://hotcopper.com.au/data/attachments/4191/4191873-0712b115931bbade60f846532642934c.jpg
    https://hotcopper.com.au/data/attachments/4191/4191876-7cacf979f6510f437fd2b99c1d52fc02.jpg
    https://hotcopper.com.au/data/attachments/4191/4191870-2aa1acbfc4f408bcfc8848ec882eb661.jpg
    EN1 Price at posting: 0.1¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
NEWS Most viewed thread today: Rio Tinto confirms approach to Arcadium Lithium
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CTV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.